Evidence map›Paper›PMID 40927686›Full record

ReviewFrontiers in bioengineering and biotechnology2025

Progress in immunoregulatory mechanisms during distraction osteogenesis.

Shiyu Huang, Aoran Zeng, Qing Yin, Qiming Yang, Bing Zou, Meiying He, Juehan Wang, Qi Pan

Abstract readReview
In one paragraph

Review in Frontiers in bioengineering and biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Shiyu HuangDepartment of Orthopaedic and Reconstructive Surgery/Pediatric Orthopaedics, South China Hospital, Medical School, Shenzhen University, Shenzhen, China.
Aoran ZengDepartment of Orthopaedic and Reconstructive Surgery/Pediatric Orthopaedics, South China Hospital, Medical School, Shenzhen University, Shenzhen, China.
Qing YinSchool of Basic Medical Sciences, Medical School, Shenzhen University, Shenzhen, China.
Qiming YangDepartment of Orthopaedic and Reconstructive Surgery/Pediatric Orthopaedics, South China Hospital, Medical School, Shenzhen University, Shenzhen, China.
Bing ZouSchool of Basic Medical Sciences, Medical School, Shenzhen University, Shenzhen, China.
Meiying HeSchool of Basic Medical Sciences, Medical School, Shenzhen University, Shenzhen, China.
Juehan WangDepartment of Orthopaedic and Reconstructive Surgery/Pediatric Orthopaedics, South China Hospital, Medical School, Shenzhen University, Shenzhen, China.
Qi PanDepartment of Orthopaedic and Reconstructive Surgery/Pediatric Orthopaedics, South China Hospital, Medical School, Shenzhen University, Shenzhen, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Distraction osteogenesis (DO) is an endogenous bone tissue engineering technique that harnesses the regenerative potential of bone and has been widely applied in limb lengthening, bone defect repair, and craniofacial reconstruction. The DO procedure consists of three distinct phases: the latency phase, the distraction phase, and the consolidation phase, each characterized by unique biological processes. In recent years, increasing attention has been directed toward the role of the immune system during DO. Emerging evidence demonstrates that immune cells exhibit dynamic and temporally regulated changes throughout the different phases of DO. Moreover, immunomodulatory clinical interventions-such as the regulation of immune-related factors and the application of bioactive materials-are becoming promising strategies for optimizing DO outcomes. This review aims to summarize the temporal characteristics of immune regulation during DO, elucidate the functions and regulatory mechanisms of various immune cells involved, and explore the potential of immunomodulatory biomaterials, thereby providing novel insights for improving DO-based therapies.

Indexed as

biomaterialsbone regenerationcytokinesdistraction osteogenesisimmunomodulation

Identifiers

PMID40927686
PMCPMC12414999

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.